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ABSTRACT
Introduction: Access to safe sanitation in low-income,
informal settlements of Sub-Saharan Africa has not
significantly improved since 1990. The combination of a
high faecal-related disease burden and inadequate
infrastructure suggests that investment in expanding
sanitation access in densely populated urban slums can
yield important public health gains. No rigorous,
controlled intervention studies have evaluated the health
effects of decentralised (non-sewerage) sanitation in an
informal urban setting, despite the role that such
technologies will likely play in scaling up access.
Methods and analysis: We have designed a
controlled, before-and-after (CBA) trial to estimate the
health impacts of an urban sanitation intervention in
informal neighbourhoods of Maputo, Mozambique,
including an assessment of whether exposures and
health outcomes vary by localised population density.
The intervention consists of private pour-flush latrines
(to septic tank) shared by multiple households in
compounds or household clusters. We will measure
objective health outcomes in approximately 760
children (380 children with household access to
interventions, 380 matched controls using existing
shared private latrines in poor sanitary conditions),
at 2 time points: immediately before the intervention
and at follow-up after 12 months. The primary
outcome is combined prevalence of selected enteric
infections among children under 5 years of age.
Secondary outcome measures include soil-transmitted
helminth (STH) reinfection in children following
baseline deworming and prevalence of reported
diarrhoeal disease. We will use exposure assessment,
faecal source tracking, and microbial transmission
modelling to examine whether and how routes
of exposure for diarrhoeagenic pathogens and
STHs change following introduction of effective
sanitation.
Ethics: Study protocols have been reviewed and
approved by human subjects review boards at the
London School of Hygiene and Tropical Medicine, the
Georgia Institute of Technology, the University of North
Carolina at Chapel Hill, and the Ministry of Health,
Republic of Mozambique.
Trial registration number: NCT02362932.
Strengths and limitations of this study
▪ The first controlled health impact trial of an
urban decentralised (non-sewerage) sanitation
intervention.
▪ Includes a matched control group.
▪ The first sanitation health impact trial of shared
sanitation.
▪ The first sanitation health impact trial that uses a
direct measure of enteric infections as a primary
outcome measure.
▪ The first sanitation health impact trial that
includes a focus on localised population density.
▪ As a controlled before-and-after (CBA) study, the
risk of residual confounding of the effect of
shared sanitation on enteric infections in children
cannot be eliminated, particularly for confound-
ing variables that change over time.
▪ Interventions are not randomly allocated; the
control group is selected on the basis of interven-
tion criteria as articulated by the implementer.
▪ Limited sample size prevents stratified analysis
of some important variables, including shared
latrine type and ages of children; the cohort now
includes children from 29 days to 48 months of
age at baseline, and risks of enteric infections
may be very different if child age is more nar-
rowly defined.
▪ Limited follow-up (12 months) makes it unlikely
that any effect on child growth or other later
impacts will be discernable; we are collecting
anthropometric data to provide a baseline for
later studies in this cohort that may reveal these
effects if present.
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INTRODUCTION
Africa is predominantly rural but rapidly urbanising. By
2050, Africa is projected to be 56% urban.1 As urban
infrastructure may not expand to serve the needs of new
urban residents emigrating from rural areas, informal,
unplanned settlements are likely to persist in urban and
periurban areas in the coming decades.2 These areas
are characterised, in part, by a lack of basic services,
overcrowding and high population density, substandard
housing, unhealthy living conditions, insecure property
tenure, lack of security, and poverty.3 4 Current estimates
are that over 65% of urban residents in Sub-Saharan
Africa (SSA) reside in such communities, but in some
cities the proportion can reach as high as 85%.
Approximately 2.5 billion people lack access to basic
‘improved’ sanitation, with an estimated 756 million in
urban areas,5 though this is likely to be an underestimate
as slums are not always included in surveys. Despite pro-
gress in overall urban sanitation access coverage and
equity as indicated by WHO/UNICEF Joint Monitoring
Programme ( JMP) metrics, residents of urbanising,
unplanned communities in the large cities of SSA experi-
ence persistently elevated disease risks associated with
poor sanitation infrastructure that does not reliably seques-
ter excreta to prevent human exposure.6 7 Although open
defaecation and ‘unimproved’ sanitation is less prevalent
in urban settings in SSA than in rural settings, these cat-
egories apply to one-third of the urban population, and
this proportion has not changed signiﬁcantly in the past
two decades.5 Although the proportion of the population
without adequate sanitation may be lower in urban areas
than in rural areas, the public health risks of unsafe
excreta disposal can be much greater within a dense
urban population compared with a low-density rural popu-
lation where open defaecation occurs largely beyond the
boundaries of human habitation. In terms of volume of
excreta produced and probability of exposure, dense
urban environments represent critical settings for targeted
sanitation improvements.8 9
Unsafe water, sanitation and hygiene (WASH) condi-
tions enable the transmission of enteric pathogens from
infected individuals to new susceptible hosts through
direct contact and/or via the environment. WASH-related
enteric infections result in diarrhoeal diseases and may
contribute to chronic inﬂammation of the gut,10 11
leading to reduced absorption of nutrients and malnutri-
tion,12 13 environmental enteric dysfunction (EED),14
growth faltering and cognitive deﬁcits,15–17 stunting,18 and
death.19 These risks are borne predominantly by children.
Although imprecisely known and context-speciﬁc, the
burden of disease from poor sanitation speciﬁcally is likely
to be high in many settings, since sanitation serves a
primary barrier against faecal contamination of the envir-
onment20 and is associated with a range of outcomes.21
We are undertaking a controlled before-and-after
(CBA) study of an urban sanitation intervention in
Maputo, Mozambique, to address two primary questions
as summarised below.
Question 1: Can urban, onsite, shared sanitation reduce
risk of enteric infections in children?
This CBA trial is intended to estimate the effect of decen-
tralised urban sanitation on the combined prevalence of
enteric infections in children. The study aims to contrib-
ute to the evidence base for sanitation generally, but will
make key contributions in three speciﬁc areas: urban sani-
tation, shared sanitation, and the reduction of enteric
infections associated with sanitation improvements.
Urban, onsite sanitation
Recent and ongoing22 sanitation health-impact evalua-
tions have focused on rural settings, partly because the
majority of people lacking access to sanitation live in
rural areas.5 23 Urban sanitation represents an important
gap in the evidence base for sanitation health impacts
generally, with few trials of sewerage,24 and no previous
trials of urban, decentralised (onsite, non-reticulated)
sanitation, despite the fact that decentralised solutions
may play a critical role in the expansion of sanitation in
informal settlements and rapidly urbanising areas where
sewerage remains unaffordable or impractical25 due to
insufﬁcient sector ﬁnancing26 and other constraints.
Onsite systems (eg, pit latrines, septic tanks) are the
most common type of sanitation in cities of low and
middle income countries,6 yet receive little attention
from policymakers and the wider sector in urban set-
tings.25 We hypothesise that onsite systems that reliably
sequester excreta from living environments will result in
lower risk of enteric infections in children living in
households served by these facilities.
Shared sanitation
Shared sanitation has not previously been studied in a
prospective, controlled trial, despite its prevalence glo-
bally5 and especially in urban, SSA.27 There is some evi-
dence that shared sanitation may be a risk factor for
diarrhoea in children,28 29 though shared latrines (SLs)
may or may not be less hygienic than individual house-
hold latrines.7 30 31 In this study, we compare new,
hygienic, shared, private latrines with existing shared,
private latrines serving household clusters or com-
pounds in an urban slum environment. We hypothesise
that when excreta is effectively contained, residents of
households sharing the same space will experience
reduced exposure to enteric pathogens, and therefore,
children living in the immediate environment will be at
reduced risk of enteric infections and disease.
Enteric infections
WASH-related diarrhoeal diseases cause an estimated
842 000 deaths/year.32 Recent meta-analyses have con-
cluded that sanitation improvements reduce the morbid-
ity burden signiﬁcantly: pooled estimates of relative risks
range from 0.72 (95% CI 0.59 to 0.88, ‘unimproved’ to
‘improved’)33 to 0.70 (95% CI 0.61 to 0.79, sewerage,
with estimated greater impacts when the initial condi-
tions are very poor).24 Similar reductions in risk have
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been estimated for soil-transmitted helminth (STHs)
infection,34 35 which may impact over 5 billion people.36
Sanitation interventions have also been linked with
reduced speciﬁc non-STH enteric infections, notably
Giardia.37 38
Although the causal pathway from sanitation conditions
to all downstream health outcomes (diarrhoea, stunt-
ing,39–41 death) includes enteric infections, multiple
non-STH enteric infections have not generally been mea-
sured directly in large trials, partly due to the prohibitive
cost of measuring multiple pathogens or logistical con-
straints. Also, aetiological work in sanitation trials has been
mostly limited to case–control studies because asymptom-
atic shedding associated with persistent enteric infections
was not thought to be as common as we now suspect it to
be.42 We also know that recurrent or persistent infections,
including asymptomatic infections, may be closely related
to stunting, cognitive deﬁcits, and other longer term
effects of sanitation-related exposures.43–48
Question 2: Do enteric infection risks and the effects of
urban sanitation vary by localised population density?
The ecology and transmission dynamics of sanitation-
related infections may vary between rural, periurban
and urban settings; between low-density and high-density
urban areas; and across other important social, spatial
and temporal gradients. The extent to which population
density affects risks of sanitation-related exposures,
outcomes and important covariates potentially affecting
the relationship between sanitation and health is import-
ant but remains poorly characterised.
Although there is evidence that childhood mortality
and overall health are improved in urban environ-
ments,49–52 on average, stark differences exist between
the urban rich and the urban poor,53 with the urban
poor often at higher risk of stunting and death compared
with rural populations.54 In informal or unplanned settle-
ments that lack critical infrastructure,55 urbanisation and
high localised population density may be accompanied
by an increased risk of person-to-person (and person–
environment–person) transmission of infectious dis-
eases56 57 (including enteric infections),58–62 increased
exposures to chemical agents associated with urban envir-
onments, and constrained local resources (space, food,
water),59 primarily impacting the poor. As water and sani-
tation infrastructure development often lags behind
housing, some urban and periurban populations—espe-
cially those in informal/illegal settlements, slums or shan-
tytowns—may be both more at risk of preventable
diarrhoeal and other infectious diseases and less able to
access infrastructure that would reduce risk.5 Using prein-
tervention data on sanitation-related exposures and
health outcomes, we will ﬁrst determine whether there is
an association between localised density and either
sanitation-related exposures or outcomes after control-
ling for potential confounders.
There is some evidence that sanitation improvements
can have a greater impact on enteric infections in
densely populated urban informal settlements than in
less densely populated communities,63 though it is also
true that potential health gains will be greater where the
baseline risks are high—and urban slums are associated
with very high burdens of disease and death53—but the
presence or extent of any effect modiﬁcation remains
uncharacterised. This study provides an opportunity to
examine the relationship between population density,
sanitation and health in urban communities where a
range of localised population density exists, and to
understand whether density is a potential effect modiﬁer
for enteric infection risk in this setting.
Research objectives and hypotheses
Objective 1: Measure the effect of a shared, onsite urban
sanitation intervention programme on enteric infections
in children. Hypothesis: the sanitation intervention
reduces the risk of enteric infections among children in
this setting.
Objective 2: Compare the risk of enteric infections in chil-
dren in high-density versus low-density urban settlements,
accounting for the inﬂuence of socioeconomic status,
access WASH, and other covariates. Hypothesis: Population
density independently inﬂuences risk of enteric infections
in children after adjusting for confounding factors.
Objective 3: Compare the effect size of the intervention
between high-density and low-density settings. Hypothesis:
The effect of the described intervention on the prevalence
of enteric pathogens is modiﬁed by localised population
density after adjustment for confounding factors.
Objective 4: Explore whether and how the changes in
sanitation coverage inﬂuence transmission dynamics of
different pathogens in high-density versus low-density
settings. Hypothesis: Sanitation access and population
density are key determinants for the transmission
dynamics of enteric pathogens.
METHODS AND ANALYSIS
Overview of study design
This will be a CBA intervention study, as described in
the online supplementary information. On the basis of
demographic information obtained in previous studies
in this setting,64 65 and the planned scope of the inter-
vention (190 latrines serving an average of 20 people
each or 3800 people in total), we expect the interven-
tion group to include at between 456 and 494 (12–13%)
children under 5 years of age (from 29 days to
48 months of age at enrolment). We expect to enrol at
least 380 children in the intervention and control
groups at baseline and then to follow-up all children
after the intervention is completed, with the goal of
obtaining baseline and follow-up data for a minimum of
345 children in each group.
CBA designs are one of a number of non-randomised
options available to study the impacts of sanitation on
health.66 Previous examples of its use in WASH research
include an analysis of the effect of municipal drinking
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water treatment enhancement (ﬁltration) on the preva-
lence of cryptosporidiosis among persons with AIDS in
Los Angeles County,67 and an evaluation of the
effects of an urban sewerage system on childhood diar-
rhoea in Tehran.68 The principal analytical approach is
to compare the postintervention outcome measures
between intervention and control groups, with the base-
line values of outcome measures serving to adjust the
effect size for potential baseline differences. The relative
advantages and disadvantages of this study design for
WASH health impact studies have been described more
fully elsewhere.69 Assuming that confounding variables
do not change over time, this approach enables reason-
able control for confounding, as household differences
affecting the postintervention outcome measures should
also affect the baseline measures of the same outcomes.
The study design can also be described as a non-
randomised cluster-allocated trial.
Study setting
Sanitation coverage and access in Maputo
An estimated, 56% of the population in urban areas of
Mozambique (∼4.5 million people) lacked access to basic
improved sanitation facilities in 2012,5 and with about
two-thirds of Mozambique’s population growth between
now and 2050 projected to be in urban areas,70 access to
safe sanitation facilities in such settings will continue to be
a critical challenge. Only an estimated 26% of the total
volume of faecal waste generated in Maputo is safely
managed. Approximately 89% of households use onsite
disposal of waste (10% have access to sewerage; an esti-
mated 1% practice open defaecation).6 Shared sanitation
represents 8% of urban sanitation in Mozambique overall,
primarily among the poorest households in unplanned
communities.5 Lack of access to safe sanitation is acute in
the informal settlements and periurban areas of Maputo,
resulting in frequent outbreaks of cholera, widespread
enteric infections,71 and elevated child mortality.72
Description of the sanitation intervention
This study is an evaluation of a sanitation project sup-
ported by the Japan Social Development Fund ( JSDF).
This project is led by the World Bank’s Water &
Sanitation Program, with Water and Sanitation for the
Urban Poor (WSUP) as co-partner with primary respon-
sibility for implementation of the onsite sanitation com-
ponent and construction of shared sanitation facilities.
Current estimates are that approximately 30 communal
sanitation blocks (CSBs, with multiple cabins/drop-
holes) and an estimated 160 SLs (with one cabin/drop-
hole) will be constructed across 11 neighbourhoods that
exhibit diversity across density and other characteristics
(susceptibility to ﬂooding, relative poverty, important
water and sanitation infrastructure access). These inter-
ventions are shared private latrines serving a minimum
of 15 people (occasionally as few as 11), with ﬂush
toilets to septic tanks (non-sewerage). CSBs also include
other amenities, such as laundry and washing facilities,
and serve a minimum of 21 people. There are seven SL
designs in current use in this programme, with the
number of cabins based on a user capacity of approxi-
mately 20 users per drop-hole and the septic tank size
and efﬂuent drainage based on the maximum number
of people being served.
Eligibility and enrolment
Eligible children will belong to households either receiv-
ing the intervention or in a selected control site (see
below). Eligible children will be between 29 days and up
to 48 months at enrolment to ensure that children are
not neonates and that all children are under 60 months
at the end line survey. The age of children will be veri-
ﬁed, where possible, through birth or immunisation
records supplied by the caregiver. We will collect com-
pound, household-level, and individual data from all
consenting households with one or more eligible chil-
dren. All children in the target age range from eligible
households will be recruited at baseline. Shared facilities
will be handed over to users beginning in January 2015,
with construction of the estimated 190 latrines following
progressively over the next 8 months.
WSUP site selection criteria for implementation of
new shared sanitation stipulates that sites must meet the
following conditions: (1) sites should be within the pre-
deﬁned project geographical scope; (2) residents must
be currently using shared sanitation in poor condition,
based on inspection by WSUP engineers; (3) sites must
usually meet WSUP criteria for a minimum number of
beneﬁciaries (15 for SLs, 21 for CSBs); (4) sites must
have a legal piped water connection nearby for possible
use with pour-ﬂush latrines; (5) residents must convey
stated demand for improved sanitation and have a stated
interest in contributing to cost: 10% total cost of the
CSBs or 15% of the cost of SLs, divided by the beneﬁ-
ciary households and over 12 months following the start
of construction; (6) sites must have available space to
implement the new facility (often replacing the space
occupied by existing shared facilities); and (7) sites must
be accessible for transport of materials during construc-
tion and to allow for later tank emptying. Prospective
project sites are then ranked according to additional cri-
teria, including prospective community cost recovery;
cross-cutting issues (gender, disabilities, HIV); environ-
mental conditions relevant to installation of the septic
tank, including sufﬁciently deep water table, acceptable
inﬁltration rate of soil for soakaway pit/drain ﬁeld for
septic efﬂuent, and ﬂooding; and users’ commitment to
be responsible for operation and maintenance through
a formalised management committee.
Control selection
At minimum, all control sites will meet site eligibility cri-
teria 2–5, though for criterion 5—stated demand and
willingness to contribute towards cost—we will use only
stated demand for improved sanitation, presented as a
hypothetical. We will progressively enrol control sites as
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we recruit intervention sites to balance study arms by
time of enrolment, and will stratify sampling by cluster
size as well. For example, the simplest, single-cabin,
shared facility serves a minimum of 15 and a maximum
of 20 individuals. After enrolling an intervention site of
this size, we will enrol a control site based on the same
population range suitable for that latrine type: existing
shared sanitation serving 15–20 people. Therefore, the
control group is effectively matched based on both size
of the compound and time of enrolment.
Control sites may be sites from within the 11 project
bairros that fail to meet criteria 6 or 7 above, or in
similar urban bairros of Maputo where shared sanitation
is found, and site criteria 2–5 are met. Bairros that are
projected to receive large infrastructure projects or
other sanitation improvements during the proposed
study period, if any, will be excluded from control selec-
tion, though none is currently projected.
Deworming
Single-dose albendazole (a broad-spectrum deworming
treatment) will be offered to everyone in intervention
and control households (and their entire compounds)
after the baseline and immediately following installation
of the functional sanitation intervention, with the excep-
tion of pregnant women and children under 12 months.
Ministry of Health (MISAU) staff, working within the
National Deworming Campaign (NDC), will administer
albendazole in accordance with MISAU standard safety
protocols and dosage guidelines. Current dosing guide-
lines are to administer 400 mg for all ages (except for
children between 12 and 24 months, who receive
200 mg in a suspension). Deworming will occur after the
baseline collection of stool samples, and as close as pos-
sible to the date of latrine handover to the compound,
up to 14 days after latrines are open for use.
Measuring density
The study setting will be urban bairros of Maputo with a
range of neighbourhood and point-level densities. As an
exclusively urban setting, the variability at the neighbour-
hood level is estimated to be between 5000 people/km2
for least-dense bairros up to approximately 50 000
people/km2.73 Localised measures of density may be
lower and higher than these estimates. We will use the fol-
lowing measures of localised density: (1) number of (a)
total people and (b) children under 48 months at base-
line within 50 m of the centre of a given household, mea-
sured in a direct line, with all members of any household
touched by the line included; (2) number of (a) total
people and (b) children under 48 months within 100 m
of the centre of a given household, measured in a direct
line, with all members of any household touched by the
line included; and (3) number of people and children
under 48 months within the shared space as deﬁned by a
household cluster (self-deﬁned common area of house-
holds sharing the latrine), measured using a
GPS-enabled area mapping tool. The ﬁrst two methods
use a rooftop-area algorithm that is calibrated using
survey data and high-resolution satellite imagery to esti-
mate numbers of people.
Intervention fidelity and adherence
This trial is intended to estimate health impacts of a
‘real world’ urban sanitation intervention, as-delivered,
similar to other recent sanitation trials.38 74 75 The inves-
tigators have no inﬂuence over the nature or schedule
of the intervention. We will collect data directly and
indirectly on the delivery of the intervention and its use
among the target population, to estimate both ﬁdelity
and adherence, with the dual goals of (1) documenting
the process of conducting the research by tracking facili-
tating factors, barriers faced, and methods for overcom-
ing challenges and (2) developing evidence-based
recommendations to inform investments, policies and
implementation of sanitation interventions to achieve
the greatest health impact. We will estimate coverage
and use of SLs for both groups (intervention and
control) and across all sites, expressed as percentages of:
planned latrines constructed, intended recipients having
unlimited access to SLs, and population who report
exclusive use at home.
Primary outcome measure: prevalence of enteric
infections in children
A few key pathogens have been identiﬁed as important
aetiological agents of moderate-to-severe diarrhoeal
disease affecting children in Mozambique.42 According to
data from the Global Enteric Multicenter Study (GEMS)
study site in Manhiça, Mozambique, among children
under 11 months (n=374), 32% of moderate-to-severe diar-
rhoea cases were due to Rotavirus, 13% to Cryptosporidium,
and 4% to adenovirus 40/41. For children aged 12–24
months (n=194 cases), Cryptosporidium and enterotoxigenic
Escherichia coli (ETEC) each accounted for 9% of cases, fol-
lowed by Shigella (6%), Rotavirus (5%), and Campylobacter
(2%). In older children, aged 24–59 months (n=112),
Shigella caused the most cases (17%) followed by Vibrio
cholerae O1 (8%). Subclinical infections are widely preva-
lent among children living in faecally contaminated set-
tings.76–78 In the GEMS study, at least one enteric
pathogen was identiﬁed in the stool of 72% of control
(asymptomatic) children, compared with 83% of symptom-
atic cases. Two or more pathogens were detected in 45% of
cases and 31% of control children, suggesting high preva-
lence of coinfection.
We deﬁne our primary outcome as combined preva-
lence of the following enteric infections in stool samples
from children: Campylobacter; Clostridium difﬁcile, Toxin
A/B; Es. coli O157; ETEC LT/ST;79 Shiga-like toxin
producing Es. coli (STEC) stx1/stx2; Salmonella; Shigella;
V. cholerae; Yersinia enterocolitica; Giardia; Cryptosporidium;
and Entamoeba histolytica. We are using a recently devel-
oped but extensively tested80–84 multiplex molecular
pathogen assay. These and other enteric infections are
increasingly thought to be related to EED and
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stunting.85 Additionally, we will detect viral pathogens
adenovirus 40/41, Norovirus GI/GII, and Rotavirus A,
though we have excluded viral infections from the
primary outcome deﬁnition.
Secondary outcomes
Combined prevalence of STH infection in children
Prevalence of STH infections across Mozambique is high
among school-aged children. A nationally representative
survey in 2009 (n=83 331 children of mean age
11.4 years) indicated STH prevalence for Ascaris lumbri-
coides to be 65.8%, followed by Trichuris trichiura (54.0%),
hookworm (38.7%), Enterobius vermicularis (24.8%),
Taenia spp (5.8%) and Hymenolepis nana (5.2%).86 STH
infection prevalence in school-aged children in Maputo
province was 37.1%. Globally, preschool-aged children
living in STH-endemic areas may also be at high risk of
STH infection37 leading to malnutrition, growth falter-
ing, delayed cognitive development, intestinal obstruc-
tion, micronutrient deﬁciency, and other effects.87
In our study, we will assess STH infection in all stool
samples collected at baseline and approximately
12 months following the intervention. Speciﬁcally, we will
measure combined prevalence of the following STHs:
A. lumbricoides, T. trichiura, and hookworm by the
Kato-Katz method.88 We will additionally measure En.
vermicularis, Taenia spp, Hymenolepis spp, and Strongyloides
stercoralis in all stool samples.
Self-reported gastrointestinal illness
We will collect caregiver-reported symptom data on all
enrolled children from all households at baseline and
end line visits, including diarrhoea, vomiting, abdominal
pain, and refusal to eat. We deﬁne diarrhoea as ≥3 loose
or liquid stools in a 24 h period, or any stools with
blood, as reported by the child’s caregiver.89 We will use
a 7-day recall period.90 91
Tertiary outcome measures
Tertiary outcome measures include: EED biomarkers
neopterin, α-antitrypsin, and myeloperoxidase in stools;92
all-cause mortality in children under 5 years at end line,
as reported by caregivers;93 height and weight by stand-
ard protocols94 to calculate weight-for-age, length-for-age,
and weight-for-height z-scores to classify wasting, stunting
and underweight, respectively;95–98 and secretory insulin-
like growth factor 1, a linear growth marker that has been
shown to increase in children with better nutrition99 and
micronutrients (eg, zinc),100 and to be associated with
chronic inﬂammation and stunting.101 102
Environmental exposures
We will collect environmental exposure indicator data
from a subset of compounds as matched preintervention
and postintervention samples, including a subsample
from each of the following categories: (1) upper density
quintile intervention, (2) lowest density quintile inter-
vention, (3) upper density quintile control and
(4) lowest density quintile control. We seek to character-
ise exposures that may be related to density in three
domains of transmission: the household, the compound,
and the immediate area around the compound. For this
reason, we have selected three key exposure indicators
that we have developed in other studies: (1) household
water samples, as an indicator of household hygiene; (2)
soil samples from key locations near latrines; and (3) ﬂy
samples, from key household and compound locations.
We will measure E. coli across all environmental samples,
with direct pathogen measures80 and microbial source
tracking in a subset of samples.103–108 Human-speciﬁc
faecal markers that performed well in a recent multila-
boratory comparison105 will be validated against local
human and animal stool to select the markers that best
balance sensitivity and speciﬁcity in the study location,
with the goal of the relative exposure risks from various
routes of transmission.109–111 Additionally, we will sample
surfaces in multiple locations across the compounds to
assess ﬁne-scale spatial trends in exposure.112 113
Geostatistical interpolation of the spatially referenced
samples will allow us to identify areas in the compound
that are prone to faecal contamination.114
Sample size: primary outcome
One hundred and ninety shared sanitation sites are
planned for construction, serving a mean of an esti-
mated minimum of 20 persons each. GEMS data have
suggested high prevalence of asymptomatic infections in
children under 5 years of age in high-risk areas;42 other
studies have shown speciﬁc infections to rapidly increase
to high prevalence after birth.115 For the primary object-
ive, we assume that end line prevalence of enteric infec-
tion will be 70% in the control arm and about 59% in
the intervention arm (RR=0.84). Assuming 80% power,
we use a standard equation for computation of sample
size116 resulting in 314 children per arm, ignoring clus-
tering. We assume that there will be two or more chil-
dren per cluster. Owing to the low mean cluster size, the
clustering effect is likely to be small. Assuming an intra-
class correlation coefﬁcient (ICC) of 0.1,38 and a design
effect of 1.1, we compute a sample size of 345 children
per arm. Assuming that about 10% of children will be
lost to follow-up, results in a sample size of 380 children
per arm.
For the analysis of effect modiﬁcation by localised
population density, we calculate a detectable difference
of 15% between higher density areas (assumed preva-
lence of 66.5% for the primary outcome) compared
with lower density areas (51.5%), postintervention and
adjusted for baseline imbalances (80% power,
ICC=0.08), and assuming the cut point for the analysis is
the median (to optimise statistical efﬁciency). The
sample size calculation for measuring the differences in
the effect of the intervention by population density is
subject to some uncertainty, however, as the distribution
of population densities is not known. Possibly, the
median is an inappropriate cut point for this analysis,
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and groups of different sizes may be compared; other
preanalysis cut points will be identiﬁed during the ana-
lysis of baseline data, as described below, reducing the
detectable difference between density strata.
Sample size: secondary outcomes
For the secondary outcome measures, we make the
same assumptions on study power, loss to follow-up and
design effect as above. For worm infections we will
combine Ascaris, hookworm and Trichuris prevalence.
Previous surveys in Maputo suggested a 37% of STH in
school-aged children.86 Our study is enrolling partici-
pants from poor backgrounds where STH prevalence is
likely to be closer to the national average of over 60%.
However, our sample is including only preschool chil-
dren where prevalence may only be half this ﬁgure. In
line with surveys from other high-prevalence settings, we
assume that in the control arm, reinfection after
deworming will be 30% or near baseline levels.117 We
will be able to detect a difference of 10%, that is, an
incidence of reinfection of 20% in the intervention arm.
For self-reported diarrhoea, we assume a 7-day period
prevalence of 9% in children under age 5. This ﬁgure
was found in a previous large-scale WSUP-funded survey
in six bairros in Maputo.65 Our study is focusing on
socially more deprived households than this survey
(which included any household with a child under
age 5). This prevalence may therefore be conservative.
Assuming a 7-day period prevalence of diarrhoea of 9%
in the control arm, we can detect a reduction to 3.5% in
the intervention arm (RR=0.4) with 80% power.
Analysis
Given that this is a study of a complex intervention and
a complex outcome, data analysis requires a balance
between methodological simplicity and statistical models
which may be more sophisticated but which rely on
many assumptions whose validity may be unknown. We
will use several analytical methods of different degrees
of sophistication.
Objective 1: estimating the effect of the intervention
on disease risk
We will use log-binomial (prevalence data), linear regres-
sion (continuous outcomes after log-transformation), or
negative binomial models (count data such as STH
counts) to compare disease risk between intervention
and control areas. Clustering by compound will be
accounted for by generalised estimating equations or
random effects depending on whether the data meet the
assumptions for these methods.118 To account for base-
line imbalances between intervention arms we will adjust
all analyses for the baseline disease risks.
Objective 2: the association between population density
and baseline disease risk
Following on the objective 1 analysis, we will create cat-
egories of different population densities to explore
whether the effect of population density is linear (which
is unlikely), followed by cubic spline models to explore
non-linear trends. Following the baseline, we will
examine the distribution of population densities and the
relationship between the primary outcome variable and
point-level density. We will then propose one or more
additional candidate cut points for the stratiﬁed analysis
based on any identiﬁed discontinuities in this relation-
ship (ie, natural cut points that appear to represent a
change in exposure levels across the stratum of density).
The chosen cut points will then be carried forward to
the main analysis postintervention to explore the poten-
tial effect modiﬁcation of the intervention impact by
population density. If no obvious cut points can be iden-
tiﬁed based on the distribution of population density or
the association between density and risk, then we will
stratify according to three cut points: (1) lower than
median, compared with median, and higher density;
(2) lower tertile of density compared with upper tertile
of density; and (3) highest quintile of density compared
with lowest quintile of density.
Objective 3: explore interaction between intervention effect
and population density
We will use the same regression models as under object-
ive 2 to examine the interaction between intervention
and population density using the a priori divisions (eg,
median, tertiles, quintiles) and a prespeciﬁed cut-off
point identiﬁed under objective 2.
Objective 4: study transmission pathways and changes
in transmission pathways following the intervention
At baseline, we will construct a structural equation
model (SEM) including a range of socioeconomic,
demographic, and water/sanitation/hygiene factors as
speciﬁed in the conceptual framework. First, a single
model will be constructed at baseline using data from
intervention and control arms combined. The model
will then be applied to intervention and control arms
separately to study baseline comparability of disease
transmission and factors inﬂuencing disease risk. We will
modify the conceptual framework and the model result-
ing from it until we achieve a good model ﬁt. The con-
ventional approach of prespecifying the causal pathways
and then testing the whole framework using SEM is not
needed in our analysis since we can make use of the
baseline data. The model that gives the best ﬁt to the
data will then be prespeciﬁed as the model to be used
for exploring changes in transmission pathways and the
differential effect of sanitation on outcomes according
to population density. Given the many options available
for analysing the data, prespecifying the model based on
the baseline data prior to exploring the main objective
will minimise the risk of choosing the models that give
the ‘nicest,’ rather than the most valid results. At
follow-up, we will use the chosen model and apply it sep-
arately to the data from intervention and control arms.
This will allow us to explore whether the intervention is
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associated with any changes in disease determinants and
strengths of different pathways compared with (1) the
baseline and (2) the control arm postintervention.
Objective 4 will further be met by developing dynamic
transmission models to integrate data collected from the
study sites to further assess the impacts of water and sani-
tation on the transmission of enteric pathogens and
STHs among children. We propose to use two integrated
modelling approaches to assess the impact of sanitation
interventions on pathogen transmission. First, for
enteric pathogens, we will employ a classic SEIR
(susceptible-exposed-infected-recovered) framework to
model transmission via multiple pathways;119 for STHs,
following modelling framework previously developed for
schistosomiasis,120 121 transmission models will be devel-
oped to track mean infection intensity (eg, mean worm
burden). For both models, environmental factors and
their impacts will be speciﬁcally considered. The models
will then be used to assess the impacts of population
density on transmission of different pathogens under dif-
ferent scenarios of sanitation interventions. To comple-
ment the population-based models, a second approach
will use an agent-based model (ABM) to characterise
explicit socioeconomic heterogeneity in household
behaviours and conditions, and individual-level suscepti-
bility, and their impacts on the sanitation-mediated
transmission.
Limitations
Potential confounders
There are numerous confounders in all observational
studies on the association between potentially poverty-
related variables (including population density) and
enteric infections. We reduce the potential for con-
founding by frequency matching on the basis of inter-
vention siting criteria, cluster size, and time of
enrolment. For the main analysis, comparison of the
prevalence of intestinal pathogens between intervention
and control postintervention, the effect of confounders
that are constant over time will be further minimised by
controlling for baseline values in outcome variables.
Adjusting the analysis of the follow-up outcome mea-
sures for the baseline values of the same measures is
likely to be superior to all other methods of achieving
balance between two groups in situations where random-
isation is not possible.62 Most potential confounding
variables that are associated with the outcome and sani-
tation conditions are likely to reﬂect socioeconomic
status and education, which are factors that are inher-
ently difﬁcult to deﬁne and measure. Unmeasured or
imprecisely measured confounders will produce residual
confounding and limit the validity of multivariate ana-
lysis. By contrast, adjusting directly for the baseline value
of the outcome measure using the same methodology at
baseline and follow-up usually means much better
control for confounding, as the potential confounders
(whether or not measured) are likely to inﬂuence the
values of the two variables similarly. The risk of residual
confounding is a concern largely in the analysis of the
cross-sectional baseline data, where we explore the asso-
ciation between population density and infection
without accounting for temporal trends. Multivariate
analysis, supported by SEM, will be used to address con-
founding. However, the risk of residual confounding
cannot be completely eliminated.
Bias
Several sources of bias are possible in this study design.
Our main method of minimising reporting bias lies in
using stool samples that are collected independent of
symptoms for the assessment of the primary outcomes,
rather than reported illness symptoms. Therefore, our
outcome markers should not be subject to reporting
bias. Taking samples only from symptomatic individuals
risks losing objectivity, as the propensity to report symp-
toms may be inﬂuenced by receiving an intervention or
not. While the team collecting the stool samples may
not be unaware of allocation status, the laboratory staff
analysing the stool samples will be kept fully blinded.
The risk of reporting bias may be low because of the
non-randomised nature of the study. Study households
will be told that they are participating in a general
health survey without revealing the speciﬁc aims of the
study. It seems unlikely that the enrolled households will
under-report or over-report disease, as our team is not
directly linked to WSUP and does not require formal
agreement of the households to be randomised. In an
ongoing London School of Hygiene and Tropical
Medicine (LSHTM)/WSUP evaluation of a sanitation
programme in six bairros of Maputo (3701 households),
data collection is carried out by an independent local
consulting ﬁrm, and is presented to study households as
a general health and demographic survey; thus far, there
is no evidence that households relate the study to the
intervention.
In a study requiring complex analytical methods,
there is a risk of bias due to arbitrarily choosing between
different statistical modelling approaches and included
variables. As outlined above, we will minimise this bias
by prespecifying the main model for the primary object-
ive based on the baseline analysis and prior to the
follow-up round. Further, we will establish a steering
committee that includes experienced senior scientists
from the main disciplines involved in this research: sani-
tation, epidemiology, microbiology and statistics.
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